Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Nov 6, 2026, 4:00 PM EST
1.320
+0.040 (3.13%)
After-hours: Nov 6, 2026, 7:35 PM EST
Autolus Therapeutics Employees
As of December 31, 2025, Autolus Therapeutics had 754 total employees, including 752 full-time and 2 part-time employees. The number of employees increased by 104 or 16.00% compared to the previous year. That makes Autolus Therapeutics the 16,920th largest employer in the world and 2,368th in the United States.
Employees
754
Change (1Y)
104
Growth (1Y)
16.00%
Revenue / Employee
$155,690
Profits / Employee
-$371,560
Market Cap
340.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 754 | 104 | 16.00% | 752 | 2 |
| Dec 31, 2024 | 650 | 179 | 38.00% | 647 | 3 |
| Dec 31, 2023 | 471 | 67 | 16.58% | 463 | 8 |
| Dec 31, 2022 | 404 | 77 | 23.55% | 399 | 5 |
| Dec 31, 2021 | 327 | -57 | -14.84% | 324 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Allogene Therapeutics | 152 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
| Agenus | 81 |
| TRex Bio | 60 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
AUTL News
- 2 days ago - Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026 - GlobeNewsWire
- 3 days ago - Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - Autolus Therapeutics assumed with a Buy at H.C. Wainwright - TheFly
- 11 days ago - Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026 - GlobeNewsWire
- 4 weeks ago - Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026 - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics management to meet virtually with William Blair - TheFly
- 7 weeks ago - Autolus Therapeutics Registration statement: Registration filing - Filings
- 7 weeks ago - Autolus Therapeutics files to sell 3.5M American Depositary Shares for holders - TheFly